Brent Suen
Chief Executive Officer chez LOGIQ, INC.
Fortune : 998 177 $ au 31/03/2024
Profil
Brent Y.
Suen is the founder of Bay2peak S A (founded in 2003), Elevation Capital (founded in 1997), Axis Trading Corp.
(founded in 1993), and Logiq, Inc. (founded in 2014).
At Logiq, Inc., he holds the title of Executive Chairman, President & CEO.
Currently, Mr. Suen is the Chairman at GoLogiq, Inc. (since 2021).
In the past, he worked as the Director of Strategic Development at SinoBiomed, Inc. (from 2008 to 2011) and as a Director at Collective Audience, Inc. (from 2023 to 2024).
Mr. Suen obtained his undergraduate degree from The University of Arkansas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
7,84% | 26/12/2023 | 1 079 578 ( 7,84% ) | 675 816 $ | 31/03/2024 |
GOLOGIQ, INC.
1,68% | 20/03/2023 | 1 061 703 ( 1,68% ) | 317 449 $ | 31/03/2024 |
LOGIQ, INC.
0,36% | 10/04/2023 | 377 842 ( 0,36% ) | 4 912 $ | 31/03/2024 |
Postes actifs de Brent Suen
| Sociétés | Poste | Début |
|---|---|---|
| LOGIQ, INC. | Chief Executive Officer | 07/01/2022 |
| GOLOGIQ, INC. | Chairman | 26/11/2021 |
Anciens postes connus de Brent Suen
| Sociétés | Poste | Fin |
|---|---|---|
SinoBiomed, Inc.
 SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Corporate Officer/Principal | 04/08/2011 |
| Axis Trading Corp. | Founder | - |
| Bay2peak S A | Founder | - |
| Elevation Capital | Founder | - |
Formation de Brent Suen
| The University of Arkansas | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LOGIQ, INC. | Technology Services |
| GOLOGIQ, INC. | Technology Services |
| Entreprise privées | 4 |
|---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
| Bay2peak S A | |
| Elevation Capital | |
| Axis Trading Corp. |
